Marie Rimbert

Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

Jaafar Bennouna, Emmanuelle Bompas, Eve Marie Neidhardt et al. · Cancer Immunology Immunotherapy · 2008 · 237 citations · Full text

γ9δ2 T, Cancer Immunosurveillance, Innacell γδ™ +12

Selection of T Cell Clones Expressing High-Affinity Public TCRs within Human Cytomegalovirus-Specific CD8 T Cell Responses

Lydie Trautmann, Marie Rimbert, Klára Echasserieau et al. · The Journal of Immunology · 2005 · 225 citations · Full text

Adaptive Immune System, T-regulatory Cell, Viral Immunity +17

Local Modulation of Antigen-Presenting Cell Development after Resolution of Pneumonia Induces Long-Term Susceptibility to Secondary Infections

Antoine Roquilly, Hamish E. G. McWilliam, Cédric Jacqueline et al. · Immunity · 2017 · 178 citations · Full text

Local Modulation, Lung Inflammation, Immunodeficiencies +7

IDO expands human CD4⁺CD25^high regulatory T cells by promoting maturation of LPS‐treated dendritic cells

Marcelo Hill, Séverine Tanguy‐Royer, Pierre‐Joseph Royer et al. · European Journal of Immunology · 2007 · 139 citations · Full text

Lymphocyte Development, Adaptive Immune System, T-regulatory Cell +23

Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors

Jaafar Bennouna, Vincent Lévy, Hélène Sicard et al. · Cancer Immunology Immunotherapy · 2010 · 100 citations · Full text

Cancer Immunosurveillance, Solid Tumors, Immunology +8